LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corporation (NASDAQ: ITEK) (the “Company” or “Inotek”), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for ocular diseases, today announced that Gary M. Phillips, MD, MBA, has been appointed to its Board of Directors. Dr. Phillips currently serves as Senior Vice President and Chief Strategy Officer at Mallinckrodt Pharmaceuticals.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
